These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 588117)

  • 1. Calmette-Guerin bacillus treatment of experimental conjunctival malignant melanoma.
    Rutgard J; Peyman GA; Frenkel M; Saks S
    Arch Ophthalmol; 1977 Dec; 95(12):2214-7. PubMed ID: 588117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular tolerance of bacillus Calmette-Guerin organisms.
    Rutgard J; Frenkel M; Peyman GA; Saks S; Stankevych A
    Arch Ophthalmol; 1977 Dec; 95(12):2210-3. PubMed ID: 337945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bacille Calmette Guérin immunostimulation in malignant melanoma.
    MacGregor AB; Falk RE; Landi S; Ambus U; Langer B
    Surg Gynecol Obstet; 1975 Nov; 141(5):747-54. PubMed ID: 1105837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of human malignant melanoma with irradiated tumor cells, oral Bacillus Calmette-Guérin, and levamisole.
    Shibata HR; Jerry LM; Lewis MG; Mansell PW; Capek A; Marquis G
    Ann N Y Acad Sci; 1976; 277(00):355-66. PubMed ID: 1069555
    [No Abstract]   [Full Text] [Related]  

  • 5. [Novel Adjuvant Therapy for Ocular Melanoma].
    Bosch JJ; Heindl LM
    Klin Monbl Augenheilkd; 2017 May; 234(5):670-673. PubMed ID: 28505674
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal disseminated bacillus Calmette-Guerin infection and arrested growth of cutaneous malignant melanoma following intralesional immunotherapy.
    de la Monte SM; Hutchins GM
    Am J Dermatopathol; 1986 Aug; 8(4):331-5. PubMed ID: 3532854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
    MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
    Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.
    Gutterman JU; Mavligit GM; Blumenshein G; Burgess MA; McBride CM; Hersh EM
    Ann N Y Acad Sci; 1976; 277(00):135-59. PubMed ID: 1069546
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer immunotherapy.
    Richman SP; Gutterman JU; Hersh EM
    Can Med Assoc J; 1979 Feb; 120(3):322-4, 329. PubMed ID: 371776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma.
    Pinsky CM; Hirshaut Y; Wanebo HJ; Fortner JG; Miké V; Schottenfeld D; Oettgen HF
    Ann N Y Acad Sci; 1976; 277(00):187-94. PubMed ID: 1069548
    [No Abstract]   [Full Text] [Related]  

  • 11. Inconsistent response of B16 melanoma to BCG immunotherapy.
    Kreider JW; Bartlett GL; Purnell DM
    J Natl Cancer Inst; 1976 Apr; 56(4):803-10. PubMed ID: 1255799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined immunotherapy in malignant melanoma. Regression of metastatic lesions in two patients concordant in timing with systemic administration of transfer factor and Bacillus Calmette-Guérin.
    Spitler LE; Levin AS; Wybran J
    Cell Immunol; 1976 Jan; 21(1):1-19. PubMed ID: 764975
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacillus Calmette-Guérin and dinitrochlorobenzene immunotherapy of chemically induced bladder tumors.
    Lamm DL; Harris SC; Gittes RF
    Invest Urol; 1977 Mar; 14(5):369-72. PubMed ID: 844999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete remission of metastatic malignant melanoma following immunotherapy with Bacillus Calmette-Guerin (BCG): report of a case.
    Coates AS; Peters M
    Aust N Z J Surg; 1977 Jun; 47(3):362-5. PubMed ID: 269705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematoporphyrin phototherapy for experimental intraocular malignant melanoma.
    Liu LH; Ni C
    Arch Ophthalmol; 1983 Jun; 101(6):901-3. PubMed ID: 6860202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG; Peters LC
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.
    Rutten VP; Klein WR; De Jong WA; Misdorp W; Steerenberg PA; De Jong WH; Den Otter W; Ruitenberg EJ
    Cancer Immunol Immunother; 1991; 34(3):186-90. PubMed ID: 1756535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of a hamster melanoma with intralesional Corynebacterium granulosum.
    Paslin D
    Br J Dermatol; 1976 Jun; 94(6):639-44. PubMed ID: 949459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of bacillus Calmette-Guérin in the treatment of advanced melanoma.
    Stewart JH; Levine EA
    Expert Rev Anticancer Ther; 2011 Nov; 11(11):1671-6. PubMed ID: 22050015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
    McCulloch PB; Dent PB; Blajchman M; Muirhead WM; Price RA
    Can Med Assoc J; 1977 Jul; 117(1):33-6. PubMed ID: 861909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.